252 related articles for article (PubMed ID: 12524575)
1. [New "atypical" neuroleptics -- the emperor's new clothes?].
Dose M
Psychiatr Prax; 2003 Jan; 30(1):1-3. PubMed ID: 12524575
[No Abstract] [Full Text] [Related]
2. [Pro and contra: basic precedence of atypical neuroleptics].
Naber D; Dose M
Psychiatr Prax; 2005 May; 32(4):163-6. PubMed ID: 15852207
[No Abstract] [Full Text] [Related]
3. [Iatrogenic psychiatric-like symptoms recognition].
Demily C; Chouinard VA; Chouinard G
Encephale; 2010 Oct; 36(5):417-24. PubMed ID: 21035632
[TBL] [Abstract][Full Text] [Related]
4. Evaluating antipsychotic medications: predictors of clinical effectiveness. Report of an expert review panel on efficacy and effectiveness.
Lalonde P
Can J Psychiatry; 2003 Apr; 48(3 Suppl 1):3S-12S. PubMed ID: 12728783
[TBL] [Abstract][Full Text] [Related]
5. [Neuroleptics in 1979 (author's transl)].
Vinar O
Cesk Psychiatr; 1980; 76(6):384-92. PubMed ID: 6110487
[No Abstract] [Full Text] [Related]
6. Tardive dyskinesia clinic.
Achimovich LM
Aust N Z J Psychiatry; 1989 Mar; 23(1):15. PubMed ID: 2564769
[No Abstract] [Full Text] [Related]
7. Added amantadine may diminish tardive dyskinesia in patients requiring continued neuroleptics.
Freudenreich O; McEvoy JP
J Clin Psychiatry; 1995 Apr; 56(4):173. PubMed ID: 7713860
[No Abstract] [Full Text] [Related]
8. [Dosage of neuroleptics (author's transl)].
Haase HJ
MMW Munch Med Wochenschr; 1980 Dec; 122(50):1808-13. PubMed ID: 6110184
[TBL] [Abstract][Full Text] [Related]
9. [Are the antipsychotic and side-effects of neuroleptics imperfectly known?].
Schulz P
Biomed Pharmacother; 1987; 41(1):31-3. PubMed ID: 2886159
[TBL] [Abstract][Full Text] [Related]
10. Modeling effective treatment of psychoses in the elderly: a focus on avoiding movement disorders.
Trosch RM
J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S247-8. PubMed ID: 15541164
[No Abstract] [Full Text] [Related]
11. Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to paliperidone.
Hsu WY; Chiu NY
J Clin Psychopharmacol; 2013 Oct; 33(5):712-3. PubMed ID: 23899637
[No Abstract] [Full Text] [Related]
12. [Drug information. Antipsychotic treatment with neuroleptics at very high dosage].
Gerlach
Ugeskr Laeger; 1977 Apr; 139(16):959-1. PubMed ID: 15341
[No Abstract] [Full Text] [Related]
13. If 'atypical' neuroleptics did not exist, it wouldn't be necessary to invent them: perverse incentives in drug development, research, marketing and clinical practice.
Charlton BG
Med Hypotheses; 2005; 65(6):1005-9. PubMed ID: 16182461
[TBL] [Abstract][Full Text] [Related]
14. Psychotic patients who become worse on neuroleptics.
Bowers MB; Swigar ME
J Clin Psychopharmacol; 1988 Dec; 8(6):417-21. PubMed ID: 2906948
[TBL] [Abstract][Full Text] [Related]
15. A new self-rating scale for detecting atypical or second-generation antipsychotic side effects.
Waddell L; Taylor M
J Psychopharmacol; 2008 May; 22(3):238-43. PubMed ID: 18541624
[TBL] [Abstract][Full Text] [Related]
16. [Dose reduction of conventional antipsychotics: does it reduce tardive dyskinesia?].
van Berkel M; Bogers JP; Bouvy PF
Tijdschr Psychiatr; 2007; 49(1):37-41. PubMed ID: 17225204
[TBL] [Abstract][Full Text] [Related]
17. [The use of bromperidol in an open study].
Hucker H
Int Pharmacopsychiatry; 1978; 13 Suppl 1():53-61. PubMed ID: 35480
[No Abstract] [Full Text] [Related]
18. Pathophysiology of antipsychotic drug-induced movement disorders.
Casey DE
J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
[TBL] [Abstract][Full Text] [Related]
19. Do atypical antipsychotic agents cause tardive dyskinesia?
Bailey KP
J Psychosoc Nurs Ment Health Serv; 2004 Oct; 42(10):14-9. PubMed ID: 15540874
[No Abstract] [Full Text] [Related]
20. Update on legal issues associated with tardive dyskinesia.
Slovenko R
J Clin Psychiatry; 2000; 61 Suppl 4():45-57. PubMed ID: 10739331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
